Navigation Links
LABS, Inc. Promotes Chad Ronholdt to VP of Strategic Development

CENTENNIAL, Colo., June 6, 2011 /PRNewswire/ -- LABS, Inc., the recognized leader in microbiology, infectious disease screening, immunological  and cell/molecular biology testing for the transplant and biomedical sciences communities, today announced that Chad Ronholdt has been promoted to Vice President of Strategic Development following two years with the company and accomplishments that have grown the LABS, Inc. client base significantly.

In Ronholdt's previous role as Director of Business Development he afforded many strategic wins for LABS, Inc., including expanding the company's depth in the microbiology, infectious disease, immunological, biologics and medical device testing offerings and growth into the molecular and cellular biology industries. In the new role of VP of Strategic Development, Ronholdt will continue to lead the laboratory's growth into new markets, and oversee the development of new proprietary offerings.

"Chad has been pivotal in accelerating LABS' growth, by securing new clients and innovating new products to best serve our customers," said Elizabeth Hearty, Chief Executive Officer of LABS Inc. "We are pleased to announce Chad's expanded responsibility in the role of VP, and are confident he will remain fundamental in the evolution of LABS, Inc., which continues its expansion."

Ronholdt has led a distinguished career in the field of medical devices and biologics for 13 years, with a solid record of transforming fundamental scientific concepts into effective products used by surgeons worldwide. He has worked with various tissue allograft and orthopaedic medical device producers as well as several research laboratories in both scientific and strategic capacities. He also served as the Chair of the American Association of Tissue Banks (AATB) Scientific and Technical Affairs Committee from 2005 to 2008.  

About LABS, Inc.

LABS, Inc. is the premier transplant medicine reference laboratory in the country that brings unparalleled consultative expertise and industry knowledge to its clients. Our FDA registered, CLIA-certified and CAP accredited testing is focused on four core competencies; infectious disease screening, microbiology, immunogenetics and cell/molecular biology, while serving  clients in a variety of industries from transplant and transfusion to implantable biologics and tissue-based devices.. LABS, Inc. is committed to respectfully fulfilling the wishes of donors by ensuring the gift is able to generate positive patient outcomes. LABS, Inc. employs over 180 people. The company headquarters is located in Centennial, CO with satellite facilities in St. Louis, MO and Philadelphia, PA. To learn more, visit

Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. GeoVax Labs, Inc. Announces First Quarter Financial Results
2. Scarguard Labs, LLC Gains Approval to Sell Scarguard in Canada
3. SCARGUARD LABS, LLC Announces Key Consumption Results Fastest Growing Brand and Second in Total Rankings
4. GeoVax Labs, Inc. Reports Data on Prototype Adjuvant - Supplemented HIV Vaccine Tested in Preclinical Animal Studies
5. GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress
6. GeoVax Labs, Inc. Moving Operations to Smyrna, Georgia
7. Formatech, Inc. to Donate Services to Formulate and Fill GeoVax Labs, Inc. HIV/AIDS Vaccine Under Its Fillanthropy(TM) Program
8. Encouraging HIV/AIDS Vaccine Trial Results Support GeoVax Labs, Inc. Strategy
9. GeoVax Labs, Inc. Provides Clinical Studies Update
10. GeoVax Labs, Inc. Announces Resignation of Director
11. GeoVax Labs, Inc. Announces First Quarter Financial Results
Post Your Comments:
(Date:6/23/2016)... June 23, 2016 /PRNewswire/ - FACIT has announced ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" ... commercialization of a portfolio of first-in-class WDR5 inhibitors ... such as WDR5 represent an exciting class of ... precision medicine for cancer patients. Substantial advances have ...
(Date:6/23/2016)... YORK , June, 23, 2016  The Biodesign ... to envision new ways to harness living systems and ... Modern Art (MoMA) in New York City ... than 130 participating students, showcased projects at MoMA,s Celeste ... Paola Antonelli , MoMA,s senior curator of architecture ...
(Date:6/23/2016)... 2016 Apellis Pharmaceuticals, Inc. today announced ... of its complement C3 inhibitor, APL-2. The trials ... dose studies designed to assess the safety, tolerability, ... in healthy adult volunteers. Forty subjects ... single dose (ranging from 45 to 1,440mg) or ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... regulatory and technical consulting, provides a free webinar on Performing Quality ... 13, 2016 at 12pm CT at no charge. , Incomplete investigations are still ...
Breaking Biology Technology:
(Date:6/21/2016)... 21, 2016 NuData Security announced today that ... of principal product architect and that Jon ... customer development. Both will report directly to ... moves reflect NuData,s strategic growth in its product ... customer demand and customer focus values. ...
(Date:6/15/2016)... New York , June 15, 2016 /PRNewswire/ ... a new market report titled "Gesture Recognition Market by ... and Forecast, 2016 - 2024". According to the report, ... USD 11.60 billion in 2015 and is estimated ... reach USD 48.56 billion by 2024.  ...
(Date:6/7/2016)... 7, 2016  Syngrafii Inc. and San Antonio ... that includes integrating Syngrafii,s patented LongPen™ eSignature "Wet" ... collaboration will result in greater convenience for SACU ... while maintaining existing document workflow and compliance requirements. ... Highlights: ...
Breaking Biology News(10 mins):